Meta‐analysis for Surrogacy: Accelerated Failure Time Models and Semicompeting Risks Modeling
dc.contributor.author | Ghosh, Debashis | en_US |
dc.contributor.author | Taylor, Jeremy M. G. | en_US |
dc.contributor.author | Sargent, Daniel J. | en_US |
dc.date.accessioned | 2012-04-04T18:42:20Z | |
dc.date.available | 2013-05-01T17:24:43Z | en_US |
dc.date.issued | 2012-03 | en_US |
dc.identifier.citation | Ghosh, Debashis; Taylor, Jeremy M. G.; Sargent, Daniel J. (2012). "Meta‐analysis for Surrogacy: Accelerated Failure Time Models and Semicompeting Risks Modeling." Biometrics 68(1). <http://hdl.handle.net/2027.42/90527> | en_US |
dc.identifier.issn | 0006-341X | en_US |
dc.identifier.issn | 1541-0420 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/90527 | |
dc.publisher | Wiley Periodicals, Inc. | en_US |
dc.publisher | Blackwell Publishing Inc | en_US |
dc.subject.other | Copula | en_US |
dc.subject.other | Latent Factor | en_US |
dc.subject.other | Linear Regression | en_US |
dc.subject.other | Multivariate Failure Time Data | en_US |
dc.subject.other | Singular Value Decomposition | en_US |
dc.subject.other | Dependent Censoring | en_US |
dc.title | Meta‐analysis for Surrogacy: Accelerated Failure Time Models and Semicompeting Risks Modeling | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Mathematics | en_US |
dc.subject.hlbtoplevel | Science | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Department of Biostatistics, University of Michigan, Ann Arbor, Michigan 48103, U.S.A. | en_US |
dc.contributor.affiliationother | Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota 55905, U.S.A. | en_US |
dc.contributor.affiliationother | Departments of Statistics and Public Health Sciences, The Pennsylvania State University, University Park, Pennsylvania 16802, U.S.A. | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/90527/1/j.1541-0420.2011.01633.x.pdf | |
dc.identifier.doi | 10.1111/j.1541-0420.2011.01633.x | en_US |
dc.identifier.source | Biometrics | en_US |
dc.identifier.citedreference | Prentice, R. L., Kalbfleisch, J. D., Peterson, A. V., Flournoy, N., Farewell, V. T., and Breslow, N. E. ( 1978 ). The analysis of failure times in the presence of competing risks. Biometrics 34, 541 – 554. | en_US |
dc.identifier.citedreference | Clayton, D. G. ( 1978 ). A model for association in bivariate life tables and its application in epidemiological studies of familial tendency in chronic disease incidence. Biometrika 65, 141 – 151. | en_US |
dc.identifier.citedreference | Daniels, M. J. and Hughes, M. D. ( 1997 ). Meta‐analysis for the evaluation of potential surrogate markers. Statistics in Medicine 16, 1515 – 1527. | en_US |
dc.identifier.citedreference | Fine, J. P., Jiang, H., and Chappell, R. ( 2001 ). On semi‐competing risks data. Biometrika 88, 907 – 919. | en_US |
dc.identifier.citedreference | Freedman, L. S., Graubard, B. I., and Schatzkin, A. ( 1992 ). Statistical validation of intermediate endpoints for chronic disease. Statistics in Medicine 11, 167 – 178. | en_US |
dc.identifier.citedreference | Gail, M. H., Pfeiffer, R., van Houwelingen, H. C., and Carroll, R. J. ( 2000 ). On meta‐analytic assessment of surrogate outcomes. Biostatistics 1, 231 – 246. | en_US |
dc.identifier.citedreference | Ghosh, D. ( 2006 ). Semiparametric inferences for the association parameter with semi‐competing risks data. Statistics in Medicine 25, 2059 – 2070. | en_US |
dc.identifier.citedreference | Ghosh, D. ( 2008 ). Semiparametric inference for surrogate endpoints with bivariate censored data. Biometrics 64, 149 – 156. | en_US |
dc.identifier.citedreference | Ghosh, D. ( 2009 ). On assessing surrogacy in a single trial setting using a semi‐competing risks paradigm. Biometrics 65, 521 – 529. | en_US |
dc.identifier.citedreference | Li, Y. and Taylor, J. M. ( 2010 ). Predicting treatment effects using biomarker data in a meta‐analysis of clinical trials. Statistics in Medicine 29, 1875 – 1889.PubMed PMID: 20680981. | en_US |
dc.identifier.citedreference | Lin, D. Y., Robins, J. M., and Wei, L. J. ( 1996 ). Comparing two failure time distributions in the presence of dependent censoring. Biometrika 83, 381 – 393. | en_US |
dc.identifier.citedreference | Louis, T. A. ( 1981 ). Nonparametric analysis of an accelerated failure time model. Biometrika 68, 381 – 390. | en_US |
dc.identifier.citedreference | Nelsen, R. ( 1999 ). An Introduction to Copulas. New York: Springer. | en_US |
dc.identifier.citedreference | Oakes, D. ( 1982 ). A model for association in bivariate survival data. Journal of the Royal Statistical Society, Series B 44, 414 – 422. | en_US |
dc.identifier.citedreference | Oakes, D. ( 1986 ). Semiparametric inference in a model for association in bivariate survival data. Biometrika 73, 353 – 361. | en_US |
dc.identifier.citedreference | Oakes, D. ( 1989 ). Bivariate survival models induced by frailties. Journal of the American Statistical Association 84, 487 – 493. | en_US |
dc.identifier.citedreference | Prentice, R. L. ( 1989 ). Surrogate endpoints in clinical trials: Definition and operational criteria. Statistics in Medicine 8, 431 – 440. | en_US |
dc.identifier.citedreference | Sargent, D. J., Wieand, H. S., Haller, D. G., Gray, R., Benedetti, J. K., Buyse, M., Labianca, R., Seitz, J. F., O'Callaghan, J., Francini, G., Grothey, A., O'Connell, M., et al. ( 2005 ). Disease‐free survival versus overall survival as a primary end point for adjuvant colon cancer studies: Individual patient data from 20,989 patients on 18 randomized clinical trials. Journal of Clinical Oncology 23, 8664 – 8670. | en_US |
dc.identifier.citedreference | Shih, J. and Louis, T. A. ( 1995 ). Inference on the association parameter in copula models for bivariate survival data. Biometrics 51, 1384 – 1399. | en_US |
dc.identifier.citedreference | Tipping, M. and Bishop, C. M. ( 1999 ). Probabilistic principal component analysis. Journal of the Royal Statistical Society, Series B 61, 611 – 622. | en_US |
dc.identifier.citedreference | van der Vaart, A. ( 2000 ). Asymptotic Statistics. Cambridge: Cambridge University Press. | en_US |
dc.identifier.citedreference | Wang, Y. and Taylor, J. M. ( 2002 ). A measure of the proportion of treatment effect explained by a surrogate marker. Biometrics 58, 803 – 812. | en_US |
dc.identifier.citedreference | Wang, W. and Wells, M. T. ( 2000 ). Model selection and semi‐parametric inference for bivariate censored data (with discussion). Journal of American Statistical Association 95, 62 – 76. | en_US |
dc.identifier.citedreference | Ying, Z. ( 1993 ). A large‐sample study of rank estimation for censored regression data. The Annals of Statistics 21, 76 – 99. | en_US |
dc.identifier.citedreference | Zeng, D. and Lin, D. Y. ( 2008 ). Efficient resampling methods for nonsmooth estimating functions. Biostatistics 9, 355 – 363. | en_US |
dc.identifier.citedreference | Burzykowski, T., Molenberghs, G., Buyse, M., Geys, H., and Renard, D. ( 2001 ). Validation of surrogate endpoints in multiple randomized clinical trials with failure‐time endpoints. Applied Statistics 50, 405 – 422. | en_US |
dc.identifier.citedreference | Burzykowski, T., Molenberghs, G., and Buyse, M. ( 2005 ). The Evaluation of Surrogate Endpoints. New York: Springer‐Verlag. | en_US |
dc.identifier.citedreference | Buyse, M. and Molenberghs, G. ( 1998 ). Criteria for the validation of surrogate endpoints in randomized experiments. Biometrics 54, 1014 – 1029. | en_US |
dc.identifier.citedreference | Buyse, M., Molenberghs, G., Burzykowski, T., Renard, D., and Geys, H. ( 2000 ). The validation of surrogate endpoints in meta‐analysis of randomized experiments. Biostatistics 1, 49 – 67. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.